- Home
- SGHT vs HYI Comparison
SGHT vs HYI Comparison
Compare SGHT & HYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- HYI
- Stock Information
- Founded
- SGHT 2011
- HYI 2010
- Country
- SGHT United States
- HYI United States
- Employees
- SGHT N/A
- HYI N/A
- Industry
- SGHT Medical Specialities
- HYI Investment Managers
- Sector
- SGHT Health Care
- HYI Finance
- Exchange
- SGHT Nasdaq
- HYI Nasdaq
- Market Cap
- SGHT 304.4M
- HYI 279.2M
- IPO Year
- SGHT 2021
- HYI N/A
- Fundamental
- Price
- SGHT $3.72
- HYI $12.21
- Analyst Decision
- SGHT Buy
- HYI
- Analyst Count
- SGHT 7
- HYI 0
- Target Price
- SGHT $6.27
- HYI N/A
- AVG Volume (30 Days)
- SGHT 229.9K
- HYI 50.6K
- Earning Date
- SGHT 11-07-2024
- HYI 01-01-0001
- Dividend Yield
- SGHT N/A
- HYI 9.59%
- EPS Growth
- SGHT N/A
- HYI N/A
- EPS
- SGHT N/A
- HYI N/A
- Revenue
- SGHT $79,543,000.00
- HYI N/A
- Revenue This Year
- SGHT $2.18
- HYI N/A
- Revenue Next Year
- SGHT $8.14
- HYI N/A
- P/E Ratio
- SGHT N/A
- HYI N/A
- Revenue Growth
- SGHT N/A
- HYI N/A
- 52 Week Low
- SGHT $3.02
- HYI $10.99
- 52 Week High
- SGHT $8.45
- HYI $12.24
- Technical
- Relative Strength Index (RSI)
- SGHT 36.80
- HYI 54.77
- Support Level
- SGHT $3.65
- HYI $12.00
- Resistance Level
- SGHT $4.04
- HYI $12.21
- Average True Range (ATR)
- SGHT 0.21
- HYI 0.11
- MACD
- SGHT 0.06
- HYI 0.02
- Stochastic Oscillator
- SGHT 8.75
- HYI 82.93
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About HYI Western Asset High Yield Defined Opportunity Fund Inc.
Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. It invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.